Suzuki S - Search Results

1

The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo.

Mitobe Y, Suzuki S, Nakagawa-Saito Y, Togashi K, Sugai A, Sonoda Y, Kitanaka C, Okada M. Mitobe Y, et al. Among authors: suzuki s. Biomedicines. 2023 Jul 12;11(7):1967. doi: 10.3390/biomedicines11071967. Biomedicines. 2023. PMID: 37509605 Free PMC article.

2

Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.

Okada M, Shibuya K, Sato A, Seino S, Watanabe E, Suzuki S, Seino M, Kitanaka C. Okada M, et al. Among authors: suzuki s. Oncol Rep. 2013 Oct;30(4):1957-64. doi: 10.3892/or.2013.2655. Epub 2013 Aug 2. Oncol Rep. 2013. PMID: 23912840

3

JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.

Okada M, Sato A, Shibuya K, Watanabe E, Seino S, Suzuki S, Seino M, Narita Y, Shibui S, Kayama T, Kitanaka C. Okada M, et al. Among authors: suzuki s. Int J Oncol. 2014 Feb;44(2):591-9. doi: 10.3892/ijo.2013.2209. Epub 2013 Dec 5. Int J Oncol. 2014. PMID: 24316756

4

Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.

Okada M, Shibuya K, Sato A, Seino S, Suzuki S, Seino M, Kitanaka C. Okada M, et al. Among authors: suzuki s. Oncotarget. 2014 Jul 15;5(13):5100-12. doi: 10.18632/oncotarget.2087. Oncotarget. 2014. PMID: 24947996 Free PMC article.

5

Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.

Seino M, Okada M, Shibuya K, Seino S, Suzuki S, Ohta T, Kurachi H, Kitanaka C. Seino M, et al. Among authors: suzuki s. Anticancer Res. 2014 Sep;34(9):4723-31. Anticancer Res. 2014. PMID: 25202050

6

JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells.

Suzuki S, Okada M, Shibuya K, Seino M, Sato A, Takeda H, Seino S, Yoshioka T, Kitanaka C. Suzuki S, et al. Oncotarget. 2015 Jan 1;6(1):458-70. doi: 10.18632/oncotarget.2693. Oncotarget. 2015. PMID: 25473894 Free PMC article.

7

Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.

Shibuya K, Okada M, Suzuki S, Seino M, Seino S, Takeda H, Kitanaka C. Shibuya K, et al. Among authors: suzuki s. Oncotarget. 2015 Jan 20;6(2):651-61. doi: 10.18632/oncotarget.2892. Oncotarget. 2015. PMID: 25528771 Free PMC article.

8

Differential contribution of ROS to resveratrol-induced cell death and loss of self-renewal capacity of ovarian cancer stem cells.

Seino M, Okada M, Shibuya K, Seino S, Suzuki S, Takeda H, Ohta T, Kurachi H, Kitanaka C. Seino M, et al. Among authors: suzuki s. Anticancer Res. 2015 Jan;35(1):85-96. Anticancer Res. 2015. PMID: 25550538

9

Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel.

Seino M, Okada M, Sakaki H, Takeda H, Watarai H, Suzuki S, Seino S, Kuramoto K, Ohta T, Nagase S, Kurachi H, Kitanaka C. Seino M, et al. Among authors: suzuki s. Oncol Rep. 2016 Jan;35(1):593-601. doi: 10.3892/or.2015.4377. Epub 2015 Nov 2. Oncol Rep. 2016. PMID: 26534836

10

GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.

Sakaki H, Okada M, Kuramoto K, Takeda H, Watarai H, Suzuki S, Seino S, Seino M, Ohta T, Nagase S, Kurachi H, Kitanaka C. Sakaki H, et al. Among authors: suzuki s. Anticancer Res. 2015 Dec;35(12):6607-14. Anticancer Res. 2015. PMID: 26637876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,385 results

Search Page

Filters